Search
Now showing items 1-10 of 22
Measuring disease progression in MS: do patients' and physicians' perspectives match?
(Amsterdam: Vrije Universiteit, 2010-12-17)
Heterogeneity in multiple sclerosis, a bio-marker approach
(Amsterdam: Vrije Universiteit, 2011-02-15)
Harmony of Citizens is the Wall of Cities: orchestrating the neurovascular unit
(Amsterdam: Vrije Universiteit, 2013-09-16)
Glucocorticoid sensitivity in multiple sclerosis; what makes the difference?
(Amsterdam: Vrije Universiteit, 2009-11-17)
Redox balances in multiple sclerosis lesion formation
(Amsterdam: Vrije Universiteit, 2007-07-06)
The role of interferon-beta in multiple scleroses
(Amsterdam: Vrije Universiteit, 2014-11-14)
Functional brain networks in multiple slerosis: linking structural pathology to clinical disability
(Amsterdam: Vrije Universiteit, 2014-12-19)
Regulation of the blood-brain barrier in health and disease: Astrocytes at the barricade
(Amsterdam: Vrije Universiteit, 2013-09-13)
The eye as a window ...: Optical coherence...
(Amsterdam: Vrije Universiteit, 2014-10-24)
Biological markers in multiple sclerosis related to disease activity and progression
(Amsterdam: Vrije Universiteit, 2007-01-12)
Ziekteactiviteit bij multiple sclerose meten in lichaamsvloeistoffen MJ Eikelenboom Multipele sclerose (MS) is een chronische aandoening van het centraal zenuwstelsel. Bij mensen met MS ontstaan er ontstekingen in de ...